HARROW, INC.

By person

13 insiders · 132 transactions

190×

Mark L. Baum holds 190 times base salary in stock. $143.77M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAUM MARK L

CHIEF EXECUTIVE OFFICER

$1.18M (6)

—

+$1.18M

3,594,256

9.59%

$143.77M

+345.1%

Kammer Robert J

Director

—

$1.10M (17)

−$1.10M

797,327

2.13%

$31.89M

−19.9%

Makary Martin A.

Director

$672.65K (2)

—

+$672.65K

45,000

0.1200%

$1.80M

—

LINDSTROM RICHARD L MD

Director

$179.00K (1)

$832.85K (5)

−$653.85K

216,100

0.5765%

$8.64M

+140.1%

Shojaei Amir

CHIEF SCIENTIFIC OFFICER

—

$450.00K (1) scheduled

−$450.00K

0.0000%

$0.00

—

Opaleye Management Inc. entity

10% owner

$11.55M (59)

$11.79M (16)

−$242.56K

3,955,028

10.55%

$158.20M

+37.7%

BOLL ANDREW R.

PRESIDENT AND CFO

$208.31K (3)

—

+$208.31K

814,679

2.17%

$32.59M

+5,331%

Graves Adrienne L

Director

$31.07K (1)

—

+$31.07K

1,000

0.0027%

$40.00K

—

SILVERNAIL LAUREN P

Director

$31.00K (1)

—

+$31.00K

1,000

0.0027%

$40.00K

—

Van Horn R. Lawrence

Director

$24.96K (1)

—

+$24.96K

1,860

0.0050%

$74.40K

—

SAHAREK JOHN P.

CEO & President, ImprimisRx

—

467,388

1.25%

$18.70M

—

Principi Anthony

Director

—

93,798

0.2502%

$3.75M

—

AUSTIN STEPHEN G

Director

—

91,987

0.2454%

$3.68M

+365.3%

Individual transactions

Insider

Date

Role

Action

Price

Amount

BAUM MARK L

12 Dec 2025

CHIEF EXECUTIVE OFFICER

Exercised, kept

180,000

$3.95

$711.00K

BOLL ANDREW R.

12 Dec 2025

PRESIDENT AND CFO

Exercised, kept

60,000

$3.95

$237.00K

BAUM MARK L

21 Jul 2025

CHIEF EXECUTIVE OFFICER

Exercised, kept

600,000

$7.87

$4.72M

SAHAREK JOHN P.

11 Sep 2024

CEO of ImprimisRx

Exercised, kept

90,000

$7.37

$663.30K

SAHAREK JOHN P.

1 Mar 2024

CEO of ImprimisRx

Exercised, kept

5,000

$8.75

$43.75K

BAUM MARK L

20 Feb 2024

CHIEF EXECUTIVE OFFICER

Exercised, kept

150,000

$10.67

$1.60M

BOLL ANDREW R.

20 Feb 2024

CHIEF FINANCIAL OFFICER

Exercised, kept

45,000

$10.67

$480.15K

SAHAREK JOHN P.

20 Feb 2024

CEO of ImprimisRx

Exercised, kept

30,000

$10.67

$320.10K

BOLL ANDREW R.

7 Feb 2024

CHIEF FINANCIAL OFFICER

Exercised, kept

7,400

$7.71

$57.05K

BAUM MARK L

7 Feb 2024

CHIEF EXECUTIVE OFFICER

Exercised, kept

15,400

$7.71

$118.73K

BAUM MARK L

3 Apr 2023

Chief Executive Officer

Exercised, kept

180,000

$8.99

$1.62M

BOLL ANDREW R.

31 Mar 2023

Chief Financial Officer

Exercised, kept

90,000

$6.00

$540.00K

BAUM MARK L

20 Jan 2022

Chief Executive Officer

Exercised, kept

125,000

$2.40

$300.00K

BAUM MARK L

22 Nov 2019

Chief Executive Officer

Exercised, kept indirect

156,000

$1.79

$279.24K

BOLL ANDREW R.

22 Nov 2019

Chief Financial Officer

Exercised, kept

39,000

$1.79

$69.81K

BOLL ANDREW R.

1 Feb 2018

Chief Financial Officer

Exercised, kept

30,000

$1.83

$54.90K

SAHAREK JOHN P.

1 Feb 2018

Chief Commercial Officer

Exercised, kept

30,000

$1.83

$54.90K

LINDSTROM RICHARD L MD

27 Apr 2017

Director

Exercised, kept indirect

100,000

$1.79

$179.00K

BAUM MARK L

19 Dec 2016

Chief Executive Officer

Exercised, kept

200,000

$1.72

$344.00K

Show all 132 transactions →

By person

Individual transactions

What was left out